Which testing strategy involves neither patient nor physician knowing the treatment assignment?

Which testing strategy involves neither patient nor physician knowing the treatment assignment?

• A. Crossover Study
• B. IND
• C. Placebo
• D. Double-Blind Study

Answer: (D)

The key idea here is reducing bias by masking who gets what. In a double-blind setup, neither the participant nor the clinician/researcher knows which treatment the participant is receiving. This prevents expectations from shaping both the patient’s reports of symptoms and the clinician’s assessments of outcomes. When outcomes can be influenced by perception or judgment—like pain, nausea, or overall improvement—keeping both sides unaware helps ensure that differences seen between treatments are due to the treatment itself, not to placebo effects or observer bias. This differs from other scenarios: a crossover design is about how participants receive multiple treatments over time, and while it can be blinded, its defining feature isn’t who is blinded. An IND is a regulatory status for studying a drug, not a blinding method. A placebo refers to an inert comparison treatment; it’s the control, not the strategy for keeping clinicians and patients unaware of allocation.

The key idea here is reducing bias by masking who gets what. In a double-blind setup, neither the participant nor the clinician/researcher knows which treatment the participant is receiving. This prevents expectations from shaping both the patient’s reports of symptoms and the clinician’s assessments of outcomes. When outcomes can be influenced by perception or judgment—like pain, nausea, or overall improvement—keeping both sides unaware helps ensure that differences seen between treatments are due to the treatment itself, not to placebo effects or observer bias.

This differs from other scenarios: a crossover design is about how participants receive multiple treatments over time, and while it can be blinded, its defining feature isn’t who is blinded. An IND is a regulatory status for studying a drug, not a blinding method. A placebo refers to an inert comparison treatment; it’s the control, not the strategy for keeping clinicians and patients unaware of allocation.